Back
Beacon Therapeutics Secures $75M+ for Vision-Restoring Gene Therapy
Back
Stock News
Themes
Beacon Therapeutics Secures $75M+ for Vision-Restoring Gene Therapy
Asset Management
Beacon Therapeutics Secures $75M+ for Vision-Restoring Gene Therapy
Edgen Stock
·
Jan 08 2026, 17:16
Share to
Share to
Copy link
source:
[1] Beacon Therapeutics Announces Closing of Oversubscribed Series C Financing for Over $75 Million
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17